GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Gross Profit

3SBio (TRSBF) Gross Profit : $1,077 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is 3SBio Gross Profit?

3SBio's gross profit for the six months ended in Jun. 2024 was $523 Mil. 3SBio's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was $1,077 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. 3SBio's gross profit for the six months ended in Jun. 2024 was $523 Mil. 3SBio's Revenue for the six months ended in Jun. 2024 was $605 Mil. Therefore, 3SBio's Gross Margin % for the quarter that ended in Jun. 2024 was 86.51%.

3SBio had a gross margin of 86.51% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 11 years, the highest Gross Margin % of 3SBio was 92.26%. The lowest was 80.86%. And the median was 82.64%.


3SBio Gross Profit Historical Data

The historical data trend for 3SBio's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Gross Profit Chart

3SBio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 691.93 828.31 813.51 930.18 1,075.22

3SBio Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 445.57 447.06 481.79 523.44 553.65

Competitive Comparison of 3SBio's Gross Profit

For the Biotechnology subindustry, 3SBio's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Gross Profit distribution charts can be found below:

* The bar in red indicates where 3SBio's Gross Profit falls into.


;
;

3SBio Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

3SBio's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1094.639 - 164.463
=930

3SBio's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=605.048 - 81.609
=523

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1,077 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

3SBio's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=523 / 605.048
=86.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


3SBio  (OTCPK:TRSBF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

3SBio had a gross margin of 86.51% for the quarter that ended in Jun. 2024 => Durable competitive advantage


3SBio Gross Profit Related Terms

Thank you for viewing the detailed overview of 3SBio's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio Business Description

Traded in Other Exchanges
Address
No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027
3SBio Inc is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics.

3SBio Headlines

No Headlines